In Germany, nearly 60% of CPAP treatment costs are Reimbursed

Increasing use of oral appliances, availability of wide range of diagnostic and therapeutic devices for sleep apnea are major factors driving the growth of the sleep apnea devices market during the forecast period. Additionally, favorable reimbursement policies for CPAP devices in developed regions such as Europe also fuels the market growth. In Germany, nearly 60% of CPAP treatment costs are reimbursed with the patient paying a small amount out of pocket.

The players operating in the sleep apnea devices market across the globe include:- ResMed Inc., Koninklijke Philips N.V., Fisher & Paykel, Braebon Medical Corporation, Compumedics Limited, BMC Medical Co., Ltd., Fisher & Paykel Healthcare Limited, SomnoMed Limited, Weinmann Emergency Medical Technology GmbH + Co. KG, Devilbiss Healthcare LLC and others.

The sleep apnea devices market is segmented on the basis of diagnostics devices, therapeutic devices and end-users. Based on diagnostic devices, global sleep apnea devices market is segmented as polysomnography devices, respiratory polygraphs, actigraphy systems and single-channel screening devices (Oximeters). Among the therapeutic devices, the polysomnography devices segment has largest market share among the diagnostics devices segment. Polysomnography device are most widely used for the diagnosis of sleep apnea and companies are engaged in new product development to achieve growth in the sleep apnea devices market.

Based on therapeutic devices, the sleep apnea devices market is segmented into facial interfaces, Adaptive Servo-Ventilation Instruments (ASV), Positive Airway Pressure (PAP) Devices, oxygen concentrators, airway clearance systems, oral appliances and accessories. Positive Airway Pressure (PAP) Devices has the largest market share among the therapeutic device segment. The portable machine is used for blowing the pressurized room air from into the upper airway which uses. Owing to these factors this market segment has the largest market size. The advantages of the PAP devices are that it is advanced, efficient and easily used.

Based on end user, the global sleep apnea devices market is segmented into hospitals and home. The hospital segment has the largest market share among the end user segment.

Geographically, the sleep apnea devices market is segmented into North America, Europe, Asia Pacific (APC), Middle East and Africa (MEA) and South and Central America (S&CAM).The market for sleep apnea devices is well established in North America region, especially in the US and Canada. The market is the US is governed by the presence of key players manufacturing sleep apnea devices such CPAP devices.

Table of Contents

1 Global Sleep Apnea Devices Market – introduction
1.1 Scope of the Study
1.2 the insight Partners Research Report Guidance

2 Global Sleep Apnea Devices Market – Key Takeaways

3 Global Sleep Apnea Devices Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.3 Global Sleep Apnea Devices Market – by Diagnostic Devices
3.4 Global Sleep Apnea Devices Market – by therapeutic Devices
3.5 Global Sleep Apnea Devices Market – by End User
3.6 Global Sleep Apnea Devices Market – by Geography
3.7 Pest Analysis
3.7.1 North America – Pest Analysis
3.7.2 Europe – Pest Analysis
3.7.3 Asia Pacific – Pest Analysis
3.7.4 Middle East & Africa – Pest Analysis
3.7.5 South & Central America – Pest Analysis

4 Global Sleep Apnea Devices Market – Key Market Dynamics
4.1 Key Market Drivers
4.1.1 increased Usage of Oral Devices
4.1.2 Technological Developments
4.1.3 Rising Geriatric Population
4.2 Key Market Restraints
4.2.1 Absence of Patient Compliance
4.3 Key Market Opportunities
4.3.1 Emerging Markets in Developing Countries
4.4 Future Trends
4.4.1 Telemedicine
4.5 Impact Analysis

5 Global Sleep Apnea Devices Market – Global
5.1 Global Sleep Apnea Devices Market Revenue Forecasts and Analysis
5.2 Global Sleep Apnea Market, by Geography - Forecasts and Analysis
5.3 Market Positioning
5.4 Performance of Key Players
5.4.1 Resmed
5.4.2 Koninklijke Philips N.V.
5.5 Expert Opinions

6 Global Sleep Apnea Devices Market – Regulatory Scenario
6.1 North America
6.1.1 Us
6.1.2 Canada
6.1.3 Mexico
6.2 Europe
6.3 Asia Pacific
6.3.1 Japan
6.3.2 China
6.3.3 india
6.4 Middle East & Africa
6.4.1 Saudi Arabia
6.4.2 South Africa
6.5 South & Central America
6.5.1 Brazil